Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial
Corey Smith(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Sweera Rehan(QIMR Berghofer Medical Research Institute), Matthew D. Solomon(Sutter Health), S. McKenzie(Mercyhurst University), Mark Holmes(Royal Adelaide Hospital), Daniel C. Chambers(Prince Charles Hospital), Ross S. Francis, Michelle A. Neller(QIMR Berghofer Medical Research Institute), Scott B. Campbell(The University of Queensland), Peter Hopkins(The University of Queensland), Leone Beagley, Chien‐Li Holmes‐Liew(Royal Adelaide Hospital), Pauline Crooks(QIMR Berghofer Medical Research Institute)
Cited by 105
Related Papers
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235